$LGN

Legence revenue rises 110.7% to $1.26 billion

Legence (NASDAQ:LGN) reported Q2 2026 revenue of $1.26 billion, up 110.7% year over year, and Adjusted EBITDA of $154.6 million. The company posted a net loss of $27.8 million and ended with $292 million cash and $1.03 billion debt. It raised FY2026 revenue guidance to $4.7–$4.8 billion and Adjusted EBITDA to $565–$585 million.

Original reporting
Published Aug 13, 2026, 2:31 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 4:59 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Legence revenue rises 110.7% to $1.26 billion — source image
Decision brief

The 30-second read

$LGNBullishMed
01

Why it matters

The combination of sharply higher revenue, raised FY guidance, and record backlog supports a bullish re-rating case, but margin compression and leverage increase the probability of volatility if execution or costs deteriorate.

02

Market read

Traders can update LGN positioning based on the raised FY revenue and Adjusted EBITDA ranges, plus backlog and book-to-bill metrics.

03

What to watch

Net leverage is 1.6x with $1.03B debt; impairments of ~$41.1M and margin decline could constrain multiple expansion even with higher guidance.

Relevance 8/10Novelty 8/10Timing: pre-market/early session after-hours earnings-style guidance update (published 2026-08-13 14:31 UTC)

Background

Legence is a building infrastructure services provider (energy efficiency, engineering, construction, maintenance) and reported Q2 2026 results with guidance updates.

Company-level read

Ticker impact

$LGNBullishMedium confidence
Context

Legence reported Q2 2026 revenue of $1.26B (+110.7% YoY) and raised full-year 2026 revenue guidance to $4.7B-$4.8B.

Expected impact

Near-term upside bias as traders reprice FY growth and EBITDA targets, tempered by gross margin decline and net leverage.

Evidence & confidence

The article provides multiple fresh datapoints for LGN: Q2 results, full-year guidance increases, backlog growth to $5.67B, and margin down to 17.4% from 21.5%, which can offset enthusiasm.

Market effects

Signals continued strength in building infrastructure services demand, but margin compression highlights execution/cost pressure risk for the group.

No explicit regional demand signals beyond commercial and industrial customer base.

Limited direct global macro linkage; primarily company-specific guidance and backlog visibility.

Counterpoint

The headline growth is heavily acquisition-driven (Bowers), while gross margin fell to 17.4%, implying quality of earnings may be weaker than revenue growth suggests.

Key entities

  • Legence

    Reported Q2 2026 revenue $1.26B (+110.7% YoY), Adjusted EBITDA $154.6M, and raised FY 2026 guidance.

  • Bowers acquisition

    Cited as contributing to revenue growth; non-GAAP revenue excluding Bowers rose 60% YoY.

Related articles

$LGNHighAI 9/10

Legence (LGN) Q2 2026 Earnings Call Transcript

Legence (LGN) reported Q2 2026 revenue of $1.3B, up 110.7% year over year, driven by the Bowers Group acquisition and data center demand. Adjusted EBITDA rose to $154.6M, margin 12.2%. Backlog and awards were $5.7B. The company raised Q3 and full-year 2026 guidance, including FY revenue $4.7B-$4.8B and adjusted EBITDA $565M-$585M.

MedAI 8/10

Legence Q2 2026 slides: record revenue, backlog despite margin pressure

Legence Corp. reported Q2 2026 results on Aug. 13, citing record revenue and backlog growth tied to data center and mission-critical building systems demand. Revenue rose to $1.262B (+111% YoY) and backlog to $5.67B (+105%). Adjusted EPS was -$0.37 vs +$0.21 expected. Shares fell over 7% to $63.68; full-year guidance was raised to $4.7B-$4.8B revenue.

$LGNMed

Legence Q3 Results: Sales Guidance $1.225B

Legence (NASDAQ: LGN) guided Q3 sales to $1.225B to $1.275B, above the $1.080B analyst consensus. The low end is about $145M higher, implying roughly 13% above street expectations. No other financial metrics were provided in the source.

Med

Legence Corp. Revises Earnings Guidance for Full Year 2026

Legence Corp. revised its full-year 2026 earnings guidance, raising expected total revenues to $4.7 billion to $4.8 billion from a prior range of $4.1 billion to $4.3 billion. The company provides engineering, installation and maintenance services for mission-critical building systems, operating in Engineering & Consulting and Installation & Maintenance segments.